Orgenesis and Atvio Biotech Launch Joint Venture for Gene and Cell Therapy Development Services
August 01, 2016 09:00 ET | Orgenesis Inc.
GERMANTOWN, MD--(Marketwired - Aug 1, 2016) - Orgenesis Inc. (OTCQB: ORGS), a fully integrated cell therapy and contract development and manufacturing company (the "Company" or "Orgenesis") has...
As Diabetes Becomes
As Diabetes Becomes Global Epidemic, PharmaCyte Biotech's Insulin Producing Cells Receive 20 Years of Protection
July 19, 2016 09:00 ET | PharmaCyte Biotech, Inc.
NEW YORK, NY--(Marketwired - July 19, 2016) - Worldwide the number of people living with diabetes has reached 422 million, and if the current trend continues, over 700 million people are expected to...
NLA LOGO - USE.png
Leading Cardiologist Dr. Neil Stone Secured as Speaker for the National Lipid Association Conference
July 18, 2016 12:47 ET | National Lipid Association
JACKSONVILLE, FL--(Marketwired - July 18, 2016) - Award-winning cardiologist, Neil J. Stone, MD, FACC, FNLA, will be the keynote speaker at the National Lipid Association (NLA) Clinical Lipid Update...
Eastgate Biotech Fea
Eastgate Biotech Featured on Uptick Newswire
July 11, 2016 07:15 ET | EastGate Pharmaceuticals Inc
West Caldwell, NJ and Toronto, Canada, July 11, 2016 (GLOBE NEWSWIRE) -- WEST CALDWELL, NJ and TORONTO, July 11, 2016 (GlobeNewsire/-) EastGate Biotech Corp. (Pink Sheets: ETBI), an emerging...
PharmaCyte Biotech U
PharmaCyte Biotech Uses "Artificial Liver" to Treat Advanced Pancreatic Cancer
July 07, 2016 09:00 ET | PharmaCyte Biotech, Inc.
NEW YORK, NY--(Marketwired - July 07, 2016) - PharmaCyte Biotech's (OTCQB: PMCB) signature live-cell encapsulation technology, Cell-in-a-Box®, is being used in treatments for both cancer and...
Antidiabetics Market
Antidiabetics Market size worth USD 116 Billion by 2023: Global Market Insights Inc.
July 05, 2016 11:00 ET | Global Market Insights
Ocean View, Delaware, July 05, 2016 (GLOBE NEWSWIRE) -- Global Antidiabetics Market size is estimated to reach USD 116.1 billion by 2023; as per the latest research report by Global Market...
welldoc logo.jpg
WellDoc®, a Digital Health Technology Leader, Expands Leadership Team with Roster of Seasoned Healthcare Executives
June 28, 2016 07:45 ET | WellDoc Inc.
BALTIMORE, Md., June 28, 2016 (GLOBE NEWSWIRE) -- Digital health technology leader WellDoc® has expanded its leadership team with two new C-level executives and a key executive director. Healthcare...
Rooke
New Morehouse Healthcare Specialty Works to Reverse Existing Health Conditions, Prevent New Ones
June 21, 2016 10:36 ET | Morehouse School of Medicine
ATLANTA, GA, GA., June 21, 2016 (GLOBE NEWSWIRE) -- True healing begins when the whole patient is treated. This is the philosophy that drives the Optimal Health and Wellness Clinic, a new specialty...
welldoc logo.jpg
WellDoc® Announces Results of a Collaborative Study Showing Sustained Patient Engagement through the Use of BlueStar® and Lay Coaching
June 11, 2016 11:00 ET | WellDoc Inc.
– Data Unveiled During Poster Presentation at the American Diabetes Association’s 76th Scientific Sessions – – Collaboration in a Primary Care Setting Supports a New Model of Care – BALTIMORE, June ...
Orgenesis and CureCell Awarded Grant From the KORIL Fund for Diabetes Research and Development
June 07, 2016 09:00 ET | Orgenesis Inc.
GERMANTOWN, MD--(Marketwired - Jun 7, 2016) - Orgenesis Ltd., a wholly-owned subsidiary of Orgenesis Inc. (OTCQB: ORGS), a fully integrated cell therapy and regenerative medicine company with a...